We studied the cross-sectional relationship between HbA1c and cardiovascular disease (CVD) in the survivors of the original cohort of the Framingham Heart Study (n = 1045). HbA1c was significantly related to prevalent CVD among women but not men. HbA1c was also related to hypertension and to the ratio of total to high-density lipoprotein cholesterol levels. In regression analyses that controlled for these and other potential risk factors, HbA1c remained significantly related to CVD among women. The relative odds of CVD increased 1.39-fold (95% confidence interval 1.06–1.83) for increases in HbA1c of 1% (e.g., for HbA1c from 5 to 6%). The relationship was not weakened when known diabetic subjects or subjects taking β-blocker or thiazide medications were excluded from analysis. In contrast, there was no significant relationship between “casual” blood glucose and prevalent CVD. Our results reveal a strong, significant, independent association between hyperglycemia, measured by HbA1c, and CVD among older women.
Skip Nav Destination
Article navigation
Original Articles|
February 01 1992
Association of HbA1c With Prevalent Cardiovascular Disease in the Original Cohort of the Framingham Heart Study
Daniel E Singer;
Daniel E Singer
Framingham Heart Study, National Heart, Lung and Blood Institute
Framingham, Massachusetts
; General Internal Medicine Unit and the Diabetes Unit, Department of Medicine, Massachusetts General Hospital
Boston, Massachusetts
; Department of Health Care Policy, Harvard Medical School
Boston, Massachusetts
; Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Evans Memorial Department of Clinical Research, University Hospital at Boston University Medical Center
Boston, Massachusetts
Search for other works by this author on:
David M Nathan;
David M Nathan
Framingham Heart Study, National Heart, Lung and Blood Institute
Framingham, Massachusetts
; General Internal Medicine Unit and the Diabetes Unit, Department of Medicine, Massachusetts General Hospital
Boston, Massachusetts
; Department of Health Care Policy, Harvard Medical School
Boston, Massachusetts
; Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Evans Memorial Department of Clinical Research, University Hospital at Boston University Medical Center
Boston, Massachusetts
Search for other works by this author on:
Keaven M Anderson;
Keaven M Anderson
Framingham Heart Study, National Heart, Lung and Blood Institute
Framingham, Massachusetts
; General Internal Medicine Unit and the Diabetes Unit, Department of Medicine, Massachusetts General Hospital
Boston, Massachusetts
; Department of Health Care Policy, Harvard Medical School
Boston, Massachusetts
; Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Evans Memorial Department of Clinical Research, University Hospital at Boston University Medical Center
Boston, Massachusetts
Search for other works by this author on:
Peter W F Wilson;
Peter W F Wilson
Framingham Heart Study, National Heart, Lung and Blood Institute
Framingham, Massachusetts
; General Internal Medicine Unit and the Diabetes Unit, Department of Medicine, Massachusetts General Hospital
Boston, Massachusetts
; Department of Health Care Policy, Harvard Medical School
Boston, Massachusetts
; Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Evans Memorial Department of Clinical Research, University Hospital at Boston University Medical Center
Boston, Massachusetts
Search for other works by this author on:
Jane C Evans
Jane C Evans
Framingham Heart Study, National Heart, Lung and Blood Institute
Framingham, Massachusetts
; General Internal Medicine Unit and the Diabetes Unit, Department of Medicine, Massachusetts General Hospital
Boston, Massachusetts
; Department of Health Care Policy, Harvard Medical School
Boston, Massachusetts
; Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Evans Memorial Department of Clinical Research, University Hospital at Boston University Medical Center
Boston, Massachusetts
Search for other works by this author on:
Address correspondence and reprint requests to Daniel E. Singer, MD, General Internal Medicine Unit, Bulfinch 1, Massachusetts General Hospital, Boston, MA 02114.
Diabetes 1992;41(2):202–208
Article history
Received:
June 03 1991
Revision Received:
November 01 1991
Accepted:
November 01 1991
PubMed:
1733810
Citation
Daniel E Singer, David M Nathan, Keaven M Anderson, Peter W F Wilson, Jane C Evans; Association of HbA1c With Prevalent Cardiovascular Disease in the Original Cohort of the Framingham Heart Study. Diabetes 1 February 1992; 41 (2): 202–208. https://doi.org/10.2337/diab.41.2.202
Download citation file:
484
Views